# Xandar Kardian

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xandar-kardian

- Industry: Software
- Headquarters: Toronto, Canada
- Website: www.xkcorp.com
- Total disclosed funding: $10M
- Latest round: Series A (Dec 14, 2021)
- Investors on record: 3

## About

Xandar Kardian Inc., based in Toronto, Canada, specializes in advanced radar-based monitoring technologies for healthcare and built environments, enhancing patient care and safety through innovative solutions.Founded in 2017, Xandar Kardian develops radar technology for continuous health monitoring and occupancy data. The company was established by Sam Yang and Sung Cho. Xandar Kardian has raised USD 10.00 mn in its Series A funding round on December 14, 2021, co-led by Phoenix Venture Partners, Portfolia, and Taronga Group. The company is focused on expanding its operations and technology development to improve health monitoring solutions.Xandar Kardian specializes in advanced radar-based monitoring technologies, primarily for healthcare and built environments. Their flagship products, the XK300 and XK300-H sensors, facilitate contactless, continuous vital signs monitoring and occupancy data using ultra-wideband radar technology, enhancing patient compliance and care in home healthcare settings. Their solutions are also applicable in correctional health facilities, ensuring real-time monitoring of inmates’ vital signs to prevent avoidable deaths. The company serves healthcare facilities, correctional institutions, and the commercial real estate sector, with deployments across the United States, Canada, the United Kingdom, and Ireland.Xandar Kardian generates revenue through direct sales of monitoring devices and subscription-based services for data analytics and support. Transactions typically occur in B2B relationships, where healthcare facilities and correctional institutions purchase the XK300 and XK300-H devices. Clients may also enter into partnership agreements for technology integration and support services, enhancing operational efficiency and quality of care. The revenue model benefits from the growing demand for health equity solutions and autonomous monitoring, allowing organizations to optimize resources while providing comprehensive care.Following its Series A funding round in December 2021, where Xandar Kardian raised USD 10.00 mn, the company plans to utilize this funding to expand its operations and development efforts. There are intentions to launch new products aimed at enhancing health monitoring solutions, although specific details on products and release dates have not been disclosed. Additionally, Xandar Kardian is targeting expansion into new geographic markets, though specific regions for this expansion have not been specified.

## Funding rounds

- Series A, Dec 14, 2021, $10M — Phoenix Venture Partners, Taronga Group, Portfolia

## Investors

- Phoenix Venture Partners — Series A
- Taronga Group — Series A
- Portfolia (https://capitalatlas.ai/funds/portfolia) — Series A